THE WIRE · № 75947
Plasma Fractionation Market worth $52.58 billion by 2031
01 THE MACHINE READ
WHY IT MATTERS.
A plasma fractionation market forecast implies steady biologics demand growth, but it is vendor research without company-level detail.
Steady plasma-fractionation growth forecast, vendor research
Company guidance on plasma volumes
Vendor-sponsored forecast, no company specifics
FULL DISPATCH
DELRAY BEACH, Fla., Oct. 12, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Plasma Fractionation Market is projected to reach USD 52.58 billion by 2031 from USD 36.44 billion in 2026, at a CAGR of 7.6% during the forecast period. Browse 517 market data Tables and 53 Figures...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
Prader-Willi Syndrome Market to Expand by 2036 as New Therapeutic Opportunities Address Unmet Clinical Needs2026-10-12 14:31 UTC
Raymond Douglas, MD, PhD, Unveils Research on Six-Week Teprotumumab Dosing to Help Protect Hearing2026-10-12 14:42 UTC
Racura Oncology Cleared to Escalate RC220 to 100 mg/m2 in Phase 1 HARNESS-1 Trial in EGFR-Mutant Non-Small Cell Lung Cancer2026-10-12 11:00 UTC
REGENXBIO to Host Investor Event Highlighting Surabgene Lomparvovec (Sura-vec) in Wet AMD on October 202026-10-12 11:05 UTC
Keenova Presents a New TERLIVAZ® (terlipressin) Exploratory Analysis at American College of Gastroenterology Annual Meeting2026-10-12 11:30 UTC
Retension Pharmaceuticals exceeds target with $45M IPO2026-10-12 11:53 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.